Please try another search
Mezzion Pharma Co.,Ltd. engages in the development, manufacturing, and sale of pharmaceutical products in South Korea. It is developing udenafil, a PDE5 protein for the treatment of erectile dysfunction, benign prostatic hyperplasia, portal hypertension, pulmonary arterial hypertension, and single heart failure diseases. The company was formerly known as Dong-A Pharmtech Co., Ltd. and changed its name to Mezzion Pharma Co.,Ltd. in April 2013. Mezzion Pharma Co.,Ltd. was founded in 2002 and is headquartered in Seoul, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Won-Bae Kim | 66 | - | Director |
Dong-Hyun Park | 68 | - | Chairman, CEO & President |
Jefferson J. Gregory | 68 | 2014 | Director |
Dong-Hoon Lee | 67 | - | Independent Outside Director |
Cheol-Shik Shin | 70 | - | Independent Outside Director |
Won-Am Cho | 62 | - | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review